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Abstract
Skin-derived antileukoproteinase (SKALP), also known as 
elafin, is a serine proteinase inhibitor first discovered in ke- 
ratinocytes from hyperproliferative human epidermis. In 
addition to the proteinase inhibiting domain which is di­
rected against polymorphonuclear leukocyte (PMN) de­
rived enzymes such as elastase and proteinase 3, SKALP 
contains multiple transglutaminase (TGase) substrate do­
mains which enable crosslinking to extracellular and cell 
envelope proteins. Here we show that SKALP is constitu- 
tively expressed in several epithelia that are continuously 
subjected to inflammatory stimuli, such as the oral cavity 
and the vagina where it co-localizes with type 1 TGase. All 
epithelia from sterile body cavities are negative for SKALP. 
In general, stratified squamous epithelia are positive, 
whereas pseudostratified epithelia, simple/glandular epithe­
lia and normal epidermis are negative. SKALP was found in 
fetal tissues of the oral cavity from 17 wk gestation onwards 
where it continued to be expressed up to adult life. Remark­
ably, in fetal epidermis SKALP was found from week 28 on­
wards, but was downregulated to undetectable levels in neo­
natal skin within three months, suggesting a role during 
pregnancy in feto-maternal interactions or in the early m at­
uration phase of the epidermis. Immunoelectron micros­
copy revealed the presence of SKALP in secretory vesicles 
including the lamellar granules. In culture models for epi­
dermal keratinocytes we found that expression of the en­
dogenous SKALP gene provided protection against cell de­
tachment caused by purified elastase or activated PMNs. 
Addition of exogenous recombinant SKALP fully pro­
tected the keratinocytes against PMN-dependent detach­
ment whereas superoxide dismutase and catalase were only 
marginally effective. These findings strongly suggest that 
the constitutive expression of SKALP in squamous epithe­
lia, and the inducible expression in epidermis participate in 
the control of epithelial integrity, by inhibiting PMN derived 
proteinases. (J. Clin. Invest 1996.98:1389-1399.) Key words:
proteinase inhibitor « epithelium • epidermis • elastase •poly­
morphonuclear leukocyte
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Introduction
Systemic regulation of proteinase activity is performed by nu­
merous plasma-derived inhibitors that are involved in regula­
tion of complement activation, clotting, and fibrinolysis. In ad­
dition to these systemic anti proteinases a number of locally 
acting inhibitors is known. These include inhibitors of cysteine 
proteinases such as the cystalins (1), and tissue inhibitors of 
metalloproteinases (2). Although the vast majority of the 
serine proteinase inhibitors is found in the circulation, a lim­
ited number of this class is locally active at the tissue level. 
Secretory leukocyte proteinase inhibitor (SLPI),1 an inhibitor 
of the polymorphonuclear leukocyte derived proteinases elastase 
and cathepsin G, is produced by cells of mucosal surfaces and 
is found in the corresponding epithelial lining fluid (3). In pre­
vious studies we and others have described an epidermal pro­
teinase inhibitor which was found to be partially homologous 
to SLPI. This inhibitor, termed skin-derived antileukoprotein­
ase (SKALP), otherwise known as elafin or ESI, is absent in 
normal epidermis but is highly expressed in psoriatic epidermis 
and in some epithelial cell lines (4-8), SKALP inhibits PMN- 
derived elastase and proteinase 3 and is therefore putatively 
involved in regulation of cutaneous inflammation (9, 10). We 
have previously characterized SKALP in biochemical and cell 
biological studies (6,11). The cDNA and gene of SKALP have 
been cloned and sequenced, and the chromosomal localization 
was assigned to chromosome region 20ql2-ql3 (6, 1.2, 13). 
Apart from the COOH-terminal domain which harbors the 
proteinase inhibiting properties, the SKALP molecule also 
contains a domain with putative transglutaminase substrate 
motifs which enable crosslinking to the cornified envelope pro­
teins (6, 14). Previous studies in epidermis, cultured kerati­
nocytes, and human epidermal tumors showed that SKALP 
expression patterns appear to be similar to that of cytokeratin 
16, which is known to be expressed in the context of hyperpro­
liferation (see references 15 and 16 for reviews on epidermal 
differentiation). We have recently obtained evidence that de­
creased levels of SKALP could be implicated in the pathogen­
esis of pustular forms of psoriasis (17). Apart from its presence 
in inflamed epidermis, SKALP/elafin has been reported in tra­
cheal tissue (18) and in bronchial secretions, although the ex-
Abbreviations used, in this paper: CK, cytokeratin; KGM/FCS, kera- 
tinocyte growth medium supplemented with fetal calf serum; KGM/- 
GF, keratinocyte growth medium depleted of growth factors; PMN, 
polymorphonuclear leukocyte; SKALP, skin-derived antileukopro­
teinase; SLPI, secretory leukocyte proteinase inhibitor; SOD, super­
oxide dismutase; TGase, transglutaminase.
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act cellular source of sputum-derived SKALP/elafin in vivo is 
unclear (7).
It is not known to what extent SKALP is expressed in nor­
mal adult human epithelia, and no functional studies have 
been performed so far. Here we report that SKALP is consti­
tutive! y expressed in many adult epithelia that are exposed to 
environmental stimuli. In these tissues the presence of inflam­
matory cells is physiological, suggesting that SKALP provides 
protection against excessive proteolysis. Although normal hu­
man epidermis is negative, SKALP was transiently expressed 
during fetal and neonatal development of the epidermis. In 
functional assays using cultured cells we observed a protective 
effect of epithelial SKALP expression against the action of 
leukocytic proteinases, suggesting that SKALP is involved in 
the maintenance of epithelial integrity.
Materials and Methods
Materials. Goat anti-rabbit IgG biotin conjugate, avidin-alkaline 
phosphatase, and the chromogenic substrates 5-bromo-4-ch loro-3- 
indolyl phosphate, nitroblue tetrazolium, Ca-ionophore 23187, and 
aminoethyl carbazole (AEC) were obtained from Sigma Chemical 
Co., (St. Louis, MO). Swine anti-rabbit Ig conjugated with horserad­
ish peroxidase was obtained from Dakopatts (Glostrup, Denmark). 
The Vectastain ABC kits for monoclonal and polyclonal antibodies 
purchased from Vector Laboratories Inc., (Burlingame, CA). A  syn­
thetic peptide comprising amino acid 23 to 36 of SKALP was synthe­
sized by Hurosequence, (Groningen, The Netherlands); at the COOH 
terminus a cysteine residue was added for coupling to a carrier pro­
tein. The sulfo-SMCC kit and Sulfolink gel were obtained from 
Pierce, (Rockford, IL). RNA zol™ B was obtained From Cinna/Bio- 
lex Laboratories, Inc., (Houston, TX), and a-32PdCTP from Amer- 
sham, (Amersham, UK). Ficoll-paque was from Pharmacia, (U pp­
sala, Sweden).
Recombinant SKALP was a kind gift from Dr. Norman Russell 
(ICI Pharmaceuticals, Macclesfield, UK). As a probe for ribosomal 
28$ RNA a 2,1-kb EcoRl/Bglll fragment was used (a kind gift of Dr. 
Jan Bauman, TNO Rijswijk, The Netherlands).
Tissues. Archival and fresh biopsy/autopsy material was used for 
this study. The following adult tissues were studied with respect to 
SKALP expression: brain; cornea; tongue; palate/lingual tonsil; gin­
giva; pharynx; larynx; epiglottis; vocal fold; lung; bronchus; esopha­
gus; duodenum; colon; liver; kidney; urethra; uterine cervix; vagina; 
skin from various regions including head, ear, breast, axillar region, 
mamilla, inguinal region, pubic area, scrotum, finger, foot sole, and 
hair follicle. Punch biopsies from adult skin were taken from normal 
human volunteers and psoriatic patients. Fetal and neonatal tissues 
were available from: a 9-wk-old embryo which could be examined in 
toto, two second trimester fetuses, five third trimester fetuses, and 
two neonates. Specimens used for immunohistochemistry were fixed 
in buffered 4% formalin for at least 24 h, and embedded in paraffin. 
Tissues for in situ hybridization and Northern blot analysis were snap 
frozen in liquid nitrogen and stored at -80°C.
Antisera. A polyclonal antiserum against recombinant SKALP 
was obtained as described previously (10). A n antiserum against a 
synthetic peptide comprising amino acids 23 to 36 of SKALP was pre­
pared by coupling the peptide via a COOH-terminal cystein residue 
to chicken ovalbumin, using the sulfo-SMCC procedure according to 
the manufacturer’s instructions. This conjugate was used for immuni­
zation of a rabbit according to previously described protocols (19). 
Control serum (preimmune serum) was drawn before the immuniza­
tion procedure. The antiserum against the synthetic peptide was af­
finity purified using the synthetic peptide coupled to Sulfolink cou­
pling gel according to the manufacturer’s instructions. The two 
antisera against recombinant SKALP and against the synthetic p ep ­
tide gave identical staining patterns in histological sections. A mono­
clonal antiserum against type 1 transglutaminase was obtained from 
Sanbio, (Uden, The Netherlands). A monoclonal antibody against 
human PMN elastase was obtained from DAKO, (Copenhagen, Den­
mark). Mon 150, a monoclonal antibody against involucrin was ob­
tained as previously described (20). Ks8.12, a monoclonal antibody 
recognizing CK 13 and 16 was from Sigma Chemical Co., a mono­
clonal antibody against CK 10 (DE-K10) was obtained from ICN.
Immunohistochemistry. Biopsies were fixed in buffered 4% for­
malin for at least 24 h and processed for embedding in paraffin. Sec­
tions (6 fim) were mounted on 3-aminopropyltriethoxy-silane (Sigma 
Chemical Co.) coated slides. Sections were deparaffinized and rehy- 
drated and used for an indirect peroxidase technique. For antigen re­
trieval from paraffin sections, the slides were preLreated for 15 min in
0.1% trypsin/0.1 % CaCl2, pH 7.8, by 37°C for anti-cytokeratin 10, 30 
min in 10 mM citrate buffer for Ks8.12, and for Mon'150 a pretreat­
ment of 10 min in 10 mM citrate buffer using a microwave oven 
(Miele, M720) at 450 W was performed. After preincubation with 
20% normal swine or rabbit serum the slides were incubated for 60 
min with the antibodies and after washing with PBS they were incu­
bated with peroxidase-conjugated swine anti-rabbit Ig o r  rabbit anti­
mouse Ig for 30 min. A solution of A EC in sodium-acetate buffer, pH 
4.9, containing 0.01% H2O2 was added for 15 min after preincubation 
with sodium-acetate buffer pH 4.9. When desirable, the slides were 
counterstained with Mayer's haematoxylin (Sigma Chemical Co.) and 
mounted in glycerol gelatin. Appropriate control with preimmune 
sera or omission of the primary antibodies were performed.
Immitnocytochemical staining o f  human keratinocytes cultured on 
coverslips. Human keratinocytes were cultured on tissue culture 
coverslips (Thermanox; Miles Laboratories Inc., Naperville, IL) using 
different culture conditions (see below). Cells were fixed using either 
paraformaldehyde (1%) or aceton/methanol (50/50). Fixed cells were 
stored at -20°C. Before usage the coverslips were transferred to 4°C 
for 30 min and then dried in air at room temperature. Paraformalde­
hyde fixed cells were incubated for 15 min in 50 mM NH4Cl (in PBS, 
pH 7.5), and aceton/methanol fixed cells were incubated for 15 min in 
PBS. Cells were incubated for 10 min at 37°C with either 20% normal 
goat serum for the polyclonal antibodies (anti-SKALP) or 20% nor­
mal horse serum for the monoclonal anti-TGase antibody. After this 
incubation the coverslips were washed for 15 min in PBS and incu­
bated with the primary antibody for 1 h at 37°C. Coverslips were 
washed for 15 min in PBS and incubated for 30 min at 37°C with either 
goat anti-rabbit-biotinylated antibody or horse anti-mouse-biotiny- 
lated antibody in a dilution of 1:200. After this incubation coverslips 
were washed and incubated with a complex of avidine and biotiny- 
lated horse radish peroxidase (1:50) for 30 min at room temperature. 
Finally, coverslips were washed for 15 min in PBS and incubated with 
diaminobenzidine tetrahydrochlori.de (DAB) substrate (metal en­
hanced DAB substrate Kit; Pierce; Rockford, IL), and the reaction 
was terminated by incubating the coverslips in demineralized water. 
The coverslips were lightly stained with hematoxyline solution (Har­
ris-type; Sigma Diagnostics, St. Louis, MO) and embedded in histo­
logical mounting medium (Permount; Fisher Scientific, NJ) before 
making photographs.
Construction o f  plasmids and synthesis o f  RNA probes. We have 
previously cloned the SKALP cDNA and gene (6, 13). From the 
cDNA a 251-bp PCR product was obtained (bp +69 to +320, relative 
to the translation start site), which was subcloned into a pGEM-4 
T-vector (Promega, Madison, WI) in both orientations. The plasmid 
was linearized with Pstl to synthesize the antisense cRNA, 01* in the 
reverse orientation the control sense cRNA by T7 polymerase, using 
a digoxigenin RNA labeling kit (Boehringer Mannheim, Germany). 
The cR N A ’s were fragmented by limited alkaline hydrolysis and used 
for in situ hybridization.
In situ hybridization. Frozen sections (10 |uun) were placed on 
superfrost slides (Menzel-Glazer, Braunscheig, Germany) and heated 
for 2 min at 50°C. The sections were fixed in PBS containing 4% (vol/ 
vol) paraformaldehyde for 10 min at room temperature, air-dried, 
and rehydrated in 2X SSC 2X 5 min. Sections were then prehybrid­
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ized in hybridization buffer for at least 1 h, consisting of 4X SSC, 10% 
dextrane, 50% formamide, 0.5 mg herring sperm D N A  (Boehringer 
GmbH, Mannheim, Germany), 2 mM ED TA  and IX  D enhardt’s so- 
lution. Prehybridization and hybridization was performed at37°C. Pre- 
hybridization fluid was drained off and the slides were washed in 2X 
SSC. Hybridization was carried out in humidity chambers using the 
probe in a concentration of 100 ng/ml hybridization buffer. After 
overnight incubation sections were washed in 2X SSC at 37°C fol­
lowed by washes in 0.1 X SSC/50% formamide three times for 7 min. 
Hybridizations signals were detected using a Nucleic Acid Detection 
Kit (Boehringer GmbH). Hybridized sections were processed as fol­
lows: sections were washed for 5 min in buffer 1 (100 mM Tris, 150 
mM NaCl, pH 7.5) at room temperature followed by incubation in 
buffer 1 containing 1% blocking mix for 30 min, Anti-digoxigenin- 
antibody conjugate dilute 1:200 with buffer 1 containing 1 % blocking 
mix was applied to each section at room temperature for 2 h in a hu­
midified chamber. Slides were then washed in buffer 2 (100 mM Tris, 
50 mM Mg Cl, 100 mM NaCl, pH 9.5). A  solution of 5-bromo-4- 
chloro-indolyl phosphate and nitrobluetetrazolium (Sigma Chemical 
Co.) in buffer 2 was made immediately prior to use, filtered and 
placed in a light-proof glass tray. Sections were developed overnight 
at room temperature. The sections were washed in T E  buffer (10 mM 
Tris, 1 mM EDTA, pH 8.0), counterstained with methylene green, 
and mounted using gelatin/glycerol.
RNA isolation and Northern blot analysis. Total RN A  from cul­
tured cells or different tissues obtained from autopsy or biopsy were 
extracted with RNAzol B as suggested by the supplier. The following 
epithelial tissues were studied: tongue, pharynx, larynx, epiglottis, vo­
cal fold, lung, duodenum, colon, liver, kidney, urethra, and inguinal 
skin. For Northern blot analysis 10 jig total RN A  was fractionated on 
a denaturing 1 % agarose gel containing formaldehyde following stan­
dard procedures (21) and blotted by capillary transfer on nylon mem­
brane. After transfer, RNA was fixed to the membrane by ultraviolet 
irradiation (312 nm, 0.2 J/cm2). Hybridization was performed in phos­
phate buffer as previously described using a 0.42-kbp PvuII/EcoRI 
fragment of the SKALP cDNA clone pGESKA as a probe (6). Control 
hybridizations for equal loading were performed using a human 28S 
ribosomal RNA probe. All probes were labeled with 32P by random 
priming following standard procedures. Autoradiography was done on 
X-Omat S film (Kodak, Odijk,The Netherlands) at — 80°C with an inten­
sifying screen.
Immiinoelectron microscopy. Punch biopsies from normal and 
lesional psoriatic skin were fixed in 2 % paraformaldehyde and di­
vided into small pieces. Cryosubstitution and embedding in Lowicryl 
HM20 (Agar Scientific Ltd, Essex, England) were performed as fol­
lows: fixed tissues were stepwise infiltrated into 30% glycerol and fro­
zen in liquid propane. Dehydration in methanol at -9Q°C for 48 h, 
and embedding in Lowicryl HM20 at -50°C were both performed in a 
cryosubstitution apparatus (CS-auto; Riechert). Polymerization by 
indirect UV-light was performed for 48 h at -50°C, followed by 24 h at 
room temperature. Ultra thin skin sections on carbon coated copper 
grids were preincubated with 0.5% BSA, 0,1% gelatin, and 0.15% 
glycine in PBS. The grids were subsequently incubated with a poly­
clonal rabbit antiserum against recombinant SKALP (1:500 in PBS/ 
BSA) or the corresponding preimmune serum at the same dilution, at 
4°C for 16 h. After washing the grids were incubated in protein A 
conjugated to 10 nm colloidal gold particles (1:100 in 1% BSA in 
PBS), for 60 min at room temperature. After washing the grids were 
counterstained with uranyl acetate (10 min) and lead citrate (1 min) 
according to standard protocols. The sections were examined in a 
JEOL jemlOlO electron microscope at 80 kV.
Keratinocyte primary culture. Human epidermal keratinocytes 
were initially cultured according to the Rheinwald-Green system 
(22). Primary cultures of keratinocytes were seeded on lethally irradi­
ated (3000 rad, 3 min) Swiss mouse 3T3 fibroblasts in DMEM/F12 (3:1) 
(vol/vol) (Flow Laboratories, Irvine, Scotland) supplemented with 0.4 
ixg/ml hydrocortisone (Collaborative Research Inc., Lexington, MA), 
isoproterenol (10"6 M) (Sigma Chemical Co.), 100 U/ml penicillin
plus 100 [jug/nil streptomycin (Gibco, Breda, The Netherlands), 6% 
FCS (Seralab, Nistelrode, The Netherlands), and 10 ng/ml EG F 
(Sigma Chemical Co.). Cells were grown at 37QC, 95% relative hu­
midity, and 8 % C 0 2 in air. Liquid nitrogen stored keratinocytes from 
the primary culture were used in further experiments.
First passage and induction o f  keratinocyte differentiation. Kera­
tinocytes were seeded at 105 cells in keratinocyte growth medium 
(KGM) as described before (23). KGM was composed of kerati­
nocyte basal medium (KBM; Clonetics, San Diego, CA; 0.15 mM Cal­
cium) supplemented with ethanol amine (0.1 mM) (Sigma, St. Louis, 
MO), phosphoethanolamine (0.1 mM) (Sigma, St. Louis, MO), bo­
vine pituitary extract (BPE; 0.4% vol/vol) (Clonetics), EGF (10 ng/ 
ml) (Sigma Chemical Co.), insulin (5 |xg/ml) (Sigma Chemical Co.), 
hydrocortisone (0.5 jxg/ml) (Collaborative Research Inc.), penicillin 
(100 U/ml) (Gibco) and streptomycin (100 fxg/ml) (Gibco). For in­
duction of differentiation, at confluence the culture medium was 
switched either to KGM supplemented with 5% FCS or to KGM de­
pleted of growth factors (EGF, BPE, insulin) and hydrocortisone (11, 
24). Nondifferentiated keratinocytes, present as a confluent mono­
layer, were obtained by keeping the cells in KGM alone. After 48 h, 
the cultures were harvested either from 60 mm dishes (for RNA ex­
traction) or from 24-well plates in which the cells were cultured on 
coverslips for immunocytochemistry.
Purification o f  PMN elastase; determination o f anti-elastase activ­
ity. Human PMN elastase was purified from cells of a patient with 
chronic myeloid leukemia and calibrated as previously described (4). 
Elastase activity and anti-elastase activity was measured using the flu- 
origenic substrate methoxy-succinyl-ala-ala-ala-pro-val-aminometh- 
ylcoumarin (Bachem, Bubendorf, Switzerland), as described previ­
ously (25). The amount of inhibitor which reduces the activity of 1 
nmol elastase with 50% under the given assay conditions, is defined 
as 1 U of anti-elastase activity.
Cell detachment assays. Keratinocyte cultures on coverslips that 
were allowed to differentiate for 48 h, were extensively washed with 
PBS to  remove all traces of the induction media. To investigate 
whether SKALP was secreted under these conditions, the culture m e­
dium (serum-free KGM with 1.8 mM Ca2+) was subsequently col­
lected over a 6 h time period, and the amount of SKALP was deter­
mined by a sandwich-type ELISA using a rabbit and a goat antiserum 
against recombinant SKALP. In addition the amount of anti-elastase 
activity in the medium was determined by a functional assay. PMN 
were isolated from peripheral blood according to standard proce­
dures involving dextrane sedimentation, separation on a Ficoll-paque 
gradient and hypotonic lysis. This yielded a suspension of >  95% 
pure PMN. Subsequently, the keratinocytes were exposed to PMN 
(2.10ri per ml) activated with Ca-ionophore (1 jxM), or to purified 
PMN elastase (10-25 fig/ml) in KGM supplemented with 1,8 mM 
Ca2+. PMN from two different donors were used. When keratinocytes 
were exposed to activated PMN, the effect of excess recombinant 
SKALP (50 fig/nil) or the addition of superoxide dismutase (500 U/ml) 
plus catalase (1,000 U/ml) was tested. At regular intervals the cover­
slips were washed with PBS and fixed in ethanol for histological ex­
amination. The degree of cell detachment from the coverslip was 
quantitated by image analysis using the Vidas 2.1 system (Kontron, 
Germany), and expressed as a percentage of the total surface of the 
coverslip.
Results
SKALP is constitutively expressed in several squamous epithe­
lia. We studied SKALP expression in 21 adult human tissues 
by immunohistochemistry (Fig. 1). In these tissues the stroma 
was always negative, whereas the epithelium in a number of 
tissues studied showed positive staining. The following epithe­
lial tissues were positive for SKALP expression: tongue, pal­
ate, lingual tonsil, gingiva, pharynx, epiglottis, vocal fold,
SKA L P in H 11 n i an Ep ith elia  1391
Figure L  Immunohistochemical staining for SKALP in human epithelia. Staining was performed on formalin fixed paraffin sections, using a 
polyclonal rabbit antiserum. (/L) normal epidermis is negative except for the keratinizing cells lining the sweat gland duct (arrow); (B ) hair folli­
cle, positive cells are found in the infundibulum; in the following tissues SKALP vs strongly present in the suprabasal cells: (C) psoriatic epider­
mis; (D) tongue; (E) tonsil; (F) gingiva; (G) epiglottis; (H) esophagus; (ƒ) vagina; (J) pharynx, double stained for SKALP, which is present in 
the suprabasal epithelial layers, and for PMN elastase which is present as tlie intensely stained dots in the epidermis and the underlying der­
mis. X 90 (A and G) and X 180 (B-F, H-J).
esophagus, uterine cervix, vagina, and hair follicle. The expres­
sion varied considerably from one weakly stained cell layer (as 
in vocal folds and hair follicles) to many intensely stained su­
prabasal layers (as in esophagus and vagina). Staining was 
never seen in the basal cells. When multiple layers were 
stained, the density of the cytoplasmatic staining increased 
with increasing differentiation, often in a distinct polarized 
(apical) localization in the cytoplasm, while in other cases 
staining appeared to be localized close to the cell membrane.
Normal epidermis and skin adnexae are negative, except 
for the keratinocytes lining the epidermal part of the sweat 
gland ducts (Fig. 1 A) and the infundibular part of the hair fol­
licle (Fig. 1 B). The suprabasal cells of psoriatic epidermis are 
strongly positive (Fig. 1 C) as described previously (10). The 
tongue dorsum was strongly positive: up to 10 cell layers were 
intensively stained (Fig. 1 D). In contrast the ventral part of 
the tongue was negative (not shown). The furrows surrounding 
the vallate papillae of the tongue stained intensely, but the 
taste buds were negative. In palate/lingual tonsil a distinct 
SKALP expression was observed in destroyed epithelial lining 
(Fig. 1 E), while staining was absent in the intact cover of the 
tonsil. Keratinizing gingiva was moderately positive for three
or four most differentiated cell layers (Fig. 1 F). The lining of 
the epiglottis was positively stained in multiple layers (Fig. 1G). 
In between, areas of pseudostratified columnar cells, with ciliated 
cells common to respiratory epithelia, were negative with re­
spect to expression of SKALP. True vocal fold was slightly pos­
itive (not shown). Esophageal lining, showed many positive cell 
layers, especially the superficial layers which were intensively 
stained in a polarized pattern (Fig. 1 FI). The uterine cervix and 
vagina were positive for multiple cell layers, with varying inten­
sity. The staining appeared to be more cell membrane associ­
ated than cytoplasmatic (Fig. 1 /) . In most of these epithelia, 
infiltrating mononuclear cells and few PMNs are found in the 
connective tissue or in the epithelium itself, and their presence 
appears to be physiological. In pharynx we found a consider­
able number of PMN present. Fig. 1J  shows a double staining 
for SKALP and PMN elastase. In addition to the tissues shown 
in fig. 1 A -J  we examined a number of epithelial and non-epi- 
thelial tissues that were negative for SKALP expression, such 
as brain, cornea, larynx, lung, bronchus, duodenum, colon, liver, 
kidney, urethra, and skin from various body regions (not shown).
Because SKALP contains a number of repeats in the NH2- 
terminal domain which can be used as TGase substrate a lim-
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ited number of tissues was examined for type 1 TGase. The 
known tissue distribution (26) and our own observations indi­
cate that in psoriatic epidermis, esophagus and oral epithelia 
SKALP and TGase colocalize in the upper half of the supra­
basal compartment (not shown).
SKALP is developmental^ regulated in fetal epidermis. 
Fetal tissues (9, 17, 22, and 28/29 wk gestation) and neonatal 
tissues (1 and 3 mo post partum) were stained for SKALP. We 
studied the expression in oral epithelia, that were shown to be 
positive in the adult, and in epidermis which was negative in 
the adult (see above). For comparison we stained the tissues 
for other known differentiation-related markers such as CK 
10, CK 13/16, and involucrin (data not shown). In a 9-wk-old 
embryo, which could be examined in toto, no SKALP could be 
detected in any tissue. The periderm which is at this timepoint
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Figure 2. SKALP expression in fetal epithelia. Staining was per­
formed on formalin fixed sections. Fetal epidermis was negative up to 
week 20 (/I). From week 27-28 onwards strong epidermal staining 
was seen in the suprabasal cells (B)> SKALP expression was rapidly 
downregulated after birth. In neonatal epidermis after 1 mo a faint 
staining was visible in the upper layer of the stratum granulosum (C) 
and SKALP was undetectable at 3-mo (as in adult skin). In oral epi­
thelia SKALP was expressed as early as wk 17 (D) and continued to 
be expressed during adult life (not shown). X 90.
starting to show the first signs of stratification was also nega­
tive for CK 10, CK 13/16, and involucrin. At 22 wk gestation, 
CK 10, CK 13/16, and involucrin positive cells are found in the 
upper suprabasal layer of the epidermis, whereas SKALP is 
absent at this timepoint (Fig. 2 A). At 28 wk, SKALP expres­
sion is found in the granular layer and upper spinous layer of 
the interfollicular epidermis (Fig. 2 B). At this timepoint the 
morphology of the epidermis is similar to adult human epider­
mis, including full stratification, keratinization, suprabasal ex­
pression of CK 10 and involucrin, and the absence of CK 13/16 
in the suprabasal cells, as previously described by others (27, 
28). In neonatal epidermis 1-mo-post partum the expression of 
SKALP is still faintly detectable in the upper layer of the stra­
tum granulosum and in the stratum corneum (Fig. 2 C). In 
neonatal epidermis 3 mo post partum SKALP expression is 
completely downregulated as in normal adult skin. The expres­
sion pattern of CK 10 remains unchanged during the postnatal 
period. Involucrin expression which was found in the fetal stra- 
tupi granulosum and stratum spinosum, is only found in the 
stratum granulosum of adult epidermis. In adult interfollicular 
epidermis SKALP is completely absent, but is re-expressed 
during the hyperproliferative differentation program as seen in 
psoriasis (Fig. 1 C) and injury, where it is always co-expressed 
with CK 16. Remarkably, in the fetal and neonatal epidermis 
that was positive for SKALP no positive staining was seen with 
the Ks8.12 (anti-CK13/16) antibody, indicating that SKALP 
and CK 16 (at least in fetal development) are subjected to dis­
tinct regulatory mechanisms.
In addition to epidermis we investigated the expression of 
SKALP, CK 10, 13 /16, and involucrin in fetal and neonatal 
tongue and tonsils. SKALP was found in the suprabasal kera­
tinocytes of tongue epithelium as early as 17 wk gestation (Fig. 
2 D). In the lingual tonsils SKALP expression was found from 
28 wk onwards (no material was available from earlier time 
points). In contrast to epidermis, SKALP expression in these 
epithelia was not downregulated in neonatal skin, but contin­
ued to be present in adult life, as shown in Fig. 1.
Expression of SKALP at the mRNA level Fresh autopsy 
material was obtained, stored at -80°C, and used for Northern 
blot analysis. In tongue, pharynx, and psoriatic skin a strong 
expression of SKALP could be demonstrated whereas in epi­
glottis and vocal fold moderate levels were present (Fig. 3). In 
larynx, lung, kidney, urethra, and normal skin no SKALP 
mRNA was found. These findings correlated with the expres­
sion of SKALP at the protein level, as found with immunohis­
tochemistry.
Because our studies suggested a discrepancy with data 
from Nonamura et al. (38) who reported the focal expression 
of SKALP/elafin in normal adult epidermis as shown with in 
situ hybridization, we have examined epidermis from many 
different locations, We were unable to demonstrate SKALP 
expression at the protein level in adult epidermis from ear, 
breast, axilla, scrotum, mamilla, palms, and soles (not shown). 
Using mRNA in situ hybridization on frozen sections of nor­
mal and psoriatic skin from the trunk, our results paralelled 
the findings with immunohistochemistry (Fig. 4). With the an­
tisense cRNA probe a strong expression was found in the su­
prabasal compartment of psoriatic epidermis, whereas normal 
epidermis was negative. All tissues were negative with the 
sense cRNA probe. Our findings at the mRNA level are in 
agreement with the findings at the protein level as shown in
Fig. 1.
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Figure 3. In situ hybridization of SKALP m R N A  in human epider­
mis. Cryosections of normal human skin and lesional psoriatic skin 
were used for in situ hybridization with a digoxigenhi-labeled SKALP 
cRNA probe. Normal skin was negative both  with the antisense 
and sense probe (A  and B). Lesional psoriatic skin was strongly posi­
tive in the suprabasal cells, using the antisense probe (C). No signal 
above background was detected with the sense probe (D ). The oc­
casional alkaline phosphatase precipitate adjacent to the basal 
membrane is non-specific, and was seen bo th  with the sense and anti­
sense probe. X 90.
SKALP is present in secretory vesicles o f  epidermal keratino­
cytes. Electron microscopic examination of normal and 
lesional psoriatic epidermis revealed a positive staining of su­
prabasal keratinocytes and the stratum corneum of psoriatic 
epidermis. No significant signal was present in keratinocytes 
from normal epidermis or in melanocytes, which is in accor­
dance with the findings at the light microscopical level. Stain­
ing with the preimmune serum was negative (Fig. 5 A). As 
shown in Fig. 5 D  staining was mainly observed in the intercel­
lular spaces of the stratum corneum and over the lamellar
.  V
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Figure 4. Northern blot of SKALP m R N A  in various adult tissues. 
Lower panel. A  0.8-kb message was found in tongue (lane / ) ,  epiglot­
tis (lane2), pharynx (lane 3), vocal fold (lane 9), and in lesional psori­
atic skin which was used as the positive control (lane 11). Larynx, 
lung, kidney, urethra, skin of the inguinal region, and liver (lanes 4-8 
and 10, respectively) were negative. In the upper panel a probe for 
28S ribosomal RNA was used for control hybridizations to check for 
equal RNA loading.
granules of the keratinocytes in the upper spinous and granu­
lar layer (Fig. 5 B). In addition, intracellular labeling could 
also be observed over small vesicular structures and in the 
Golgi apparatus of these cells (not shown). Since these struc­
tures are implicated in secretion, these findings indicate syn­
thesis and secretion of SKALP from suprabasal keratinocytes.
Expression o f  SKALP protects against PMN-elastase medi­
ated cell detachment The specificity of SKALP for the PMN- 
derived proteinases elastase and proteinase 3, and its constitu­
tive expression in epithelia that are subjected to inflammatory 
stimuli suggests a role in the control of inflammation. We 
therefore investigated whether SKALP expression could pro­
tect against elastase-dependent cell damage in an in vitro sys­
tem. Human epidermal keratinocytes were cultured in KGM 
to form a confluent monolayer. At this stage, no differentia­
tion is induced and SKALP is not expressed. Differentiation 
was induced either by growth factor depletion (24) or by the 
addition of fetal calf serum (11). KGM depleted of growth fac­
tors (KGM/-GF) induces a differentiated phenotype, as as­
sessed by type 1 TGase expression, and resembles normal skin 
as witnessed by the expression of CK 1/10 and the absence of 
SKALP (29). KGM with fetal calf serum (KGM/FCS) induces 
differentiation, as assessed by the expression of type 1 TGase, 
with a psoriasiform phenotype such as sustained hyperprolifer­
ation and expression of SKALP (29). Fig. 6 shows the expres­
sion of SKALP in these culture systems at the mRNA level. 
After induction of differentiation, these cultures were washed 
extensively to remove the induction media and were placed in 
the culture medium that was used in subsequent experiments 
for coculture with PMN (KGM with 1.8 mM Ca2+, without se­
rum). The secretion of SKALP in the medium was measured 
by ELISA and in a functional assay as anti-elastase activity. 
Fig. 7 shows that during a 6 h timecourse SKALP is secreted in 
the medium by cells that were allowed to differentiate in 
KGM/FCS, whereas the cells differentiated in KGM/-GF were 
negative. Having established that the culture models differed 
in SKALP expression, the keratinocytes were exposed to puri­
fied human PMN elastase. During a 4-h time course, cell de­
tachment from the coverslips was visualized by H&E staining 
and quantitated by image analysis (Figs. 8 and 9). Kerati­
nocytes cultured in KGM/FCS (positive for SKALP synthesis 
and secretion) were found to be protected against elastase- 
dependent detachment, whereas ceils cultured in KGM/-GF 
(negative for SKALP synthesis and secretion) were fully de­
tached from the tissue culture dish. Elastase-dependent loss of 
adhesion was concentration dependent (not shown). Next we
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Figure 5. Immunoelectron microscopy of SKALP in human epidermis. (A) Psoriatic epidermis stained with pre-immune serum. An area of a ke­
ratinocyte of the spinous layer is shown, near a desmosome. No immunogold labeling was seen in any of the structures including the lamellar 
granules (arrow), (B) psoriatic epidermis stained with anti-SKALP serum. A group of labeled lamellar granules is shown (arrow) near a desmo­
some, at the cell membrane. (C) High power magnification of the same preparation as in B , with a labeled lamellar granule (arrow) and an 
empty lamellar granule (arrowhead). (D ) Stratum corneum of psoriatic epidermis stained with anti-SKALP serum. Clear labeling of the outer 
layers of the corneocytes is visible. Bar, 100 nm.
investigated whether activated PMN could also induce the ef­
fects seen with the purified enzyme. Differentiated cultures of 
keratinocytes were extensively washed and exposed to cal- 
cium-ionophore activated PMN. Experiments were performed 
in duplicate with PMN from two different donors. Within 12 h, 
activated PMN caused cell detachment in keratinocyte cul­
tures grown in KGM/-GF, although to a lesser extent than ob­
served in the concentration range of purified elastase 10- 
15% detachment after 12 h). The SKALP-expressing kerati­
nocytes (grown in KGM/FCS) were fully protected against cell 
detachment (Figs. 10 and 11). Addition of recombinant
SKALP (50 |JLg/ml) to keratinocytes cultured in KGM/-GF 
gave complete protection against PMN-mediated damage (Fig.
11 E), whereas addition of SOD (500 U/ml) plus catalase 
(1,000 U/ml) was only marginally effective (Fig. '11D).
Discussion
The proteinase inhibitor SKALP/elafin was first discovered at 
the biochemical level in psoriatic skin, which is reflected in the 
acronym SKALP (4), as a specific inhibitor of leukocyte elastase
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Figure 6. Northern blot analysis of 
SKALP expression in cultured kera­
tinocytes. Human epidermal kerati­
nocytes were induced to differentiate 
either in KGM  depleted of growth fac­
tors (KGM/-GF) or in KGM with 
KGM/FCS. In KGM /-GF (lane 2) 
SKALP is not expressed, whereas a 
strong signal is seen in KGM/FCS (lane 
1). In the upper panel control hybrid­
ization with 28S ribosomal RNA is 
shown to check for equal loading.
which is reflected in the name elafin (5), Retrospectively, both 
these names are unfortunate, since we now know, firstly, that 
SKALP is not normally present in epidermis but is constitu- 
tively expressed in other epithelia, and secondly that the inhib­
itory profile of SKALP also includes leukocyte proteinase-3 
(9). In view of its specificity for leukocytic proteinases, it was 
hypothesized that SKALP is involved in the regulation of cuta­
neous inflammation either by interfering with PMN migration 
or by providing protection against excessive proteolysis of ex­
tracellular matrix components. In previous studies we have 
documented the expression of SKALP in psoriatic epidermis, 
in injured skin and in cell culture (11). A striking parallel was 
found with the expression pattern of CIC16 which is not nor­
mally expressed in the interfollicular epidermis but is induced 
in psoriasis, after injury and in cell culture (30,31). We hypoth­
esized that both SKALP and CK 16 were part of the hyperpro- 
liferative differentiation program of normal epidermis, and 
subjected to similar control mechanisms. In the present study
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Figure 7. Secretion of SKALP in the medium of cultured keratino­
cytes. After induction of differentiation in KGM/FCS or in ICGM/-GF, 
the cells were extensively washed, and incubated in KGM  supple­
mented with 1.8 mM Ca2+, which is the medium used for detachment 
assays (see below)* During a 6"h~time course, secretion of SKALP in 
the medium was measured at the protein level by ELISA  (left-hand 
Y-axis, open circles and triangles) or measured functionally and ex­
pressed as units anti-elastase activity per ml (right-hand Y-axis, 
closed circles and triangles). Under these conditions the keratinocytes 
cultured in KGM/FCS (triangles) continued to secrete SKALP 
whereas the keratinocytes cultured in ICGM/-GF (circles) remained 
negative.
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FigureS .  Time course of cell detachment by purified PMN elastase. 
Human epidermal keratinocytes cultured on coverslips in ICGM/-GF 
(open circles) or in KGM/FCS (closed circles), were extensively 
washed, and subsequently exposed to PMN elastase (10 (xg/ml) in 
KGM  with 1.8 mM Ca2+. After 2 and 4 h cells were washed, fixed, 
and stained with I-I&E. Cell detachment was quantitated by image 
analysis.
we show that SKALP and CK 16 are not co-expressed during 
fetal and neonatal development. CK 16 is not expressed in any 
stage of development of fetal epidermis as previously described 
by others (28), whereas SKALP is expressed in the third tri­
mester and downregulated in neonatal skin. In contrast to pre­
vious reports that dealt with SKALP in epidermal keratinocytes, 
either in pathology or in cell culture, here we demonstrate 
SKALP to be expressed in normal squamous epithelia. The 
adjective “normal” in this respect should be used with caution. 
Several normal tissues are subjected to continuous mechanical 
stress or inflammatory stimuli, which may influence the struc­
ture and organization of the lining epithelium. In normal epi­
glottis, squamous metaplasia can be observed, that is partly 
functional or due to mechanical stress. Pathogens may be 
present in the pharynx of healthy individuals, and in normal 
pharynx and esophagus PMN infiltration is not considered to 
be pathological. Also in the infundibular part of the hair folli­
cle the presence of bacteria that may induce an inflammatory 
response is common. SKALP expression was demonstrated in 
the tonsillar crypts where destruction of the epithelial lining by 
lymphocytes was observed. Lymphocytes transmigrate the 
tonsillar epithelium into the crypts that also contain the 
desquamated cells of the stratified squamous epithelium, This 
passing through is accompanied by desolution of the epithe­
lium, which may be the trigger for SKALP induction as part of 
the ongoing inflammatory response.
SKALP is specific for elastase and proteinase 3 which are 
proteinases present in PMN. In addition, elastase is found in 
monocytes, albeit at lower levels than in PMN. Continuous 
trafficking of PMNs and mononuclear cells to epithelia could 
expose these tissues to breakdown of extracellular matrix pro­
teins as is known from various pathological conditions (25,32). 
Studies by several authors have shown that PMN can in vitro 
degrade extracellular matrices and cause cell detachment by
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Figure 9. H&E staining of keratinocyte cultures exposed to PMN 
elastase. Human epidermal keratinocytes cultured on coverslips in 
KGM/-GF or in KGM/FCS, were extensively washed, and subse­
quently exposed to PMN elastase (10 |xg/ml) in KGM with 1.8 mM 
Ca2+. Cells were washed, fixed and stained with H&E, After 4 h, cell 
detachment and retraction was seen in keratinocytes cultured in 
KGM/-GF (,4) whereas no signs of cell detachment were visible in 
cells cultured in KGM/FCS (B ). x 45.
distinct mechanisms involving proteolytic enzymes or oxida­
tive molecules (33-36). Recently it was shown that activated 
PMN can express cell-surface bound elastase and cathepsin G 
which provides a potent mechanism to egress from the vascu­
lature, penetrate tissues and migrate to sites of inflammation 
(34). Using cultured keratinocytes exposed to purified PMN 
elastase or to activated PMN we show that expression of
hours incubation
Figure 10. Time course of cell detachment by activated PMN. H u­
man epidermal keratinocytes cultured on coverslips in KGM/-GF or 
in KGM/FCS, were extensively washed, and subsequently exposed to 
PMN (2.106/ml) activated by Ca-ionophore (1 |jlM). Experiments 
were performed in duplicate with PMN from two different donors. 
The coverslips were washed, fixed, and stained with H&E. Cell de­
tachment was quantitated by image analysis. Between 6 and 12 h in­
cubation, cells detached from the cultures that did not express 
SKALP (keratinocytes cultured in KGM/-GF, open circles), whereas 
the SKALP expressing culture (keratinocytes cultured in KGM/FCS, 
closed circles) was fully protected.
SKALP provides protection against elastase-mediated detach­
ment in vitro. In this model system we used Ca-ionophore acti­
vation of PMN which is a powerful stimulator of lysosomal en­
zyme secretion (up to 30% of the total elastase content) and 
gives a moderate superoxide production. After 9 h of exposure
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Figure 11. H&E staining of keratinocyte cultures exposed to activated PMN. Human epidermal keratinocytes cultured on coverslips in KGM/- 
GF or in KGM/FCS, were extensively washed, and subsequently exposed to PMN (2.106/ml) activated by Ca-ionophore (1 jxM). After 12 h incu­
bation, the cells were washed, fixed, and stained with H&E. A  shows a confluent culture (KGM/FCS) after 12 h without PMN, which was taken 
as the control value. No detachment was seen in these cultures; this was also found for the KGM/-GF cultures (not shown). SKALP-expressing 
cultures (KGM/FCS) exposed to activated PMNs did not show significant detachment of cells (5), whereas in the cultures that lacked SKALP- 
expression (KGM/-GF) considerable cell detachment was noted (C). Recombinant SKALP (50 fJLg/ml) could completely prevent cell detach­
ment in the KGM/-GF cultures (E ) whereas addition of SOD (500 U/ml) plus catalase (1,000 U/ml) had only a marginal protective effect (D ).
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to activated PMN a cytopathic effect was seen on keratino­
cytes that lacked SKALP expression. The cell damage during 
this period was clearly elastase/proteinase 3 dependent since 
the addition of recombinant SKALP provided protection. In 
contrast, a high concentration of SOD and catalase did not 
protect against cell detachment and retraction. SKALP could 
protect against elastase mediated damage in two ways. The 
presence of a signal peptide and its presence in secretory vesi­
cles and lamellar bodies suggests that SKALP is secreted in 
the extracellular space, where it can neutralize its target pro­
teinases. On the other hand, the TGase substrate motifs of 
SKALP enable crosslinking to the pericellular matrix and the 
cornified envelope. SKALP/elafin was recently found to be 
crosslinked to loricrin, a component of the cornified envelope 
(14), suggesting that SKALP is crosslinked to intracellular pro­
teins, and can also act as an anchored proteinase inhibitor. We 
have recently obtained indirect evidence that SKALP is in­
volved in protection of epidermal integrity in pustular forms of 
psoriasis (17). It was shown that in forms of pustular psoriasis, 
which are characterized by a massive influx of PMN, the 
amount of epidermal SKALP is much lower than in plaque 
type psoriasis. It remains to be established whether this phe­
nomenon is caused by an intrinsic (genetic) defect in these pa­
tients, or by inactivation/clearance of SKALP.
Assuming that induction of SKALP controls excessive pro­
teolysis in adult skin, the function of fetal SKALP expression 
is not clear at the moment, since no obvious signs of inflamma­
tion are present in the fetal skin itself. It was, however, re­
cently reported that at the end of gestation increased levels of 
inflammatory cytokines are found in the amion fluid, and evi­
dence for an inflammatory response has been found in the 
forebag compartment of the uterus presumably as a result of 
leakage of microbial stimuli from the vagina and cervix into 
the uterus (37). Speculatively, SKALP expression could be in­
duced via this route to ensure protection of the fetal skin 
against proteolytic activity in the amnion fluid at the end of 
gestation. However, no evidence for the presence of inflamma­
tory cells or proteinases derived thereof in the amnion fluid, 
has been published to our knowledge. Alternatively, SKALP 
induction could be a mechanism to provide temporary protec­
tion to the epidermis of the newborn, when switching from the 
fetal submerged, sterile environment to a dry environment 
which allows colonization of the skin with microorganisms. Al­
though a fully keratinized epidermis is present at term, the 
barrier function of neonatal skin is incomplete (27). The ob­
served downregulation of SKALP in neonatal epidermis could 
therefore be related to the functional maturation of barrier 
function. It has to be noted that under conditions that compro­
mise barrier function such as tape stripping and psoriasis, 
SKALP is again induced. Recently Nonamura et al. (38) have 
described the focal presence of SKALP mRNA in normal epi­
dermis, using in situ hybridization. Here, we have studied a 
large number of samples from various locations of normal 
skin, but we failed to demonstrate significant expression of 
SKALP at the protein level. Also with in situ hybridization we 
were unable to demonstrate the presence of SKALP in normal 
skin. We do occasionally observe SKALP expression in the 
epidermis near hair follicles and acrosyringia, which may ex­
plain the focal expression found by Nonomura et a l  (38),
Remarkably, SKALP in tongue and tonsil epithelium is in­
duced much earlier than in epidermis and continues to be ex­
pressed in the neonatal phase and throughout adult life. In
many of the moist oral epithelia (and of course in the tonsils) 
the presence of inflammatory cells is physiological, as a result 
of continuous exposure to environmental and microbial stim­
uli. In adult epidermis which is a dry, keratinizing epithelium, 
inflammatory cells are not normally present, which may ex­
plain the difference in SKALP expression.
On the basis of the pattern of SKALP expression, one 
would surmise that SKALP expression is induced by inflam­
matory cells such as PMN. Interestingly, Salienave et al. dem­
onstrated induction of SKALP expression in tumor cell lines 
by the cytokines interleukin 1 (IL-1) and tumour necrosis fac­
tor alpha (TNF-a), but also by the PMN-derived proteinases 
human leukocyte elastase and cathepsin G (39). This finding 
is in line with that of Perlmutter et al. who reported that neu­
trophil elastase regulates the synthesis of its inhibitor al-pro- 
teinase inhibitor in human monocytes and bronchoalveolar 
macrophages (40). The cytokines IL-1 and TNF-a are consid­
ered to be initiating cytokines in inflammatory processes in 
cutaneous tissues (32). In normal tissues where continuous 
monitoring of the tissue by inflammatory cells is desired for 
reasons of host defense, this control mechanism might explain 
SKALP presence in epithelia such as esophagus, pharynx, 
tongue and vagina. The difference in SKALP expression in 
the various epithelia could be related to differences in inflam­
matory stimuli to which the tissues are subjected. However, 
ultimate proof for its supposed relevance in control of epithe­
lial inflammation has to come from studies using transgenic 
mice lacking a functional SKALP gene, which will be the di­
rection for future research.
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